Rachel L Stewart

Title: Rachel L Stewart: Innovator in Cancer Risk Assessment

Introduction

Rachel L Stewart is a prominent inventor based in Lexington, KY (US). She has made significant contributions to the field of cancer research, particularly in assessing the risk of cancer recurrence. Her innovative work has the potential to impact the lives of many patients facing cancer diagnoses.

Latest Patents

Rachel holds a patent for a multigene assay designed to assess the risk of recurrence of cancer. This patent includes biomarkers and methods for determining the risk of cancer recurrence in a subject. The methods involve determining the level of expression of at least one MHCII gene, assessing the level of expression of at least one TIL gene, and calculating an Immune Activation Score for the subject. Additionally, her patent provides methods for diagnosing triple-negative breast cancer (TNBC) as having the TNBC Basal-like subtype, along with methods for treating cancer in a subject.

Career Highlights

Rachel is affiliated with the University of Utah Research Foundation, where she continues her research and development in cancer diagnostics. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.

Collaborations

Rachel has collaborated with notable colleagues, including Katherine (k-t) E Varley and Philip S Bernard. These collaborations enhance the breadth and depth of her research efforts.

Conclusion

Rachel L Stewart is a dedicated inventor whose work in cancer risk assessment is paving the way for innovative diagnostic methods. Her contributions are vital in the ongoing fight against cancer, and her patent reflects her commitment to improving patient care.